Contact
Please use this form to send email to PR contact of this press release:
TG Therapeutics Announces Completion of Full Enrollment in the UNITY-CLL Phase 3 Trial
TO:
Please use this form to send email to PR contact of this press release:
TG Therapeutics Announces Completion of Full Enrollment in the UNITY-CLL Phase 3 Trial
TO: